Fiche publication
Date publication
août 2014
Journal
Journal of hepatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre
Tous les auteurs :
Vierling JM, Zeuzem S, Poordad F, Bronowicki JP, Manns MP, Bacon BR, Esteban R, Flamm SL, Kwo PY, Pedicone LD, Deng W, Dutko FJ, DiNubile MJ, Koury KJ, Helmond FA, Wahl J, Bruno S
Lien Pubmed
Résumé
HCV-infected cirrhotics may urgently need therapy but are often under-represented in clinical trials resulting in limited data to guide their management. We performed a meta-analysis of well-compensated cirrhotic patients from five Phase 3 trials.
Mots clés
Adult, Aged, Antiviral Agents, administration & dosage, Clinical Trials, Phase III as Topic, Drug Therapy, Combination, Female, Hepatitis C, Chronic, complications, Humans, Interferon-alpha, administration & dosage, Liver Cirrhosis, drug therapy, Logistic Models, Male, Middle Aged, Polyethylene Glycols, administration & dosage, Proline, administration & dosage, RNA, Viral, analysis, Recombinant Proteins, administration & dosage, Retrospective Studies, Ribavirin, administration & dosage
Référence
J. Hepatol.. 2014 Aug;61(2):200-9
